Furthermore, we isolated CD44+/CD24− breast CSC from a breast cancer cell line and examined whether simultaneous modulation of both Oct-4 and/or Nanog expression could alter the expression of EMT-related molecules and invasiveness of CSC in vitro. The gene discussed is NANOG; the disease is breast cancer.